In this monthly report you will find news and highlights in the Applied Life Sciences from OSR Health, Clearmind Medicine, Kupando, Touchlight, ProBioGen, Celonic AG, Thrombolytic Science, Devonian Health Group, SpotitEarly, Neurizon® Therapeutics Limited, AlphaRose Therapeutics and more.
In this monthly report you will find news and highlights in the Applied Life Sciences from Orphan Therapeutics Accelerator, Intermountain Health, Clearmind Medicine, BioMed X, Telum Therapeutics, ModeX Therapeutics, Icosagen, Neurizon Therapeutics Limited, Single Use Support and more.
In this monthly report you will find news and highlights in the Applied Life Sciences from i-GENETIC AI, Bright Uro, T-CURX, Pantherna Therapeutics, Cercare Medical, ProBioGen, Vetter, United Immunity and more.
In this monthly report you will find news and highlights in the Applied Life Sciences from Medical Microinstruments, OptimizeRx Corp, Orphan Therapeutics Accelerator, Robocath, Ballad Health, CVRx, ImpediMed, AiZtech Labs, Cardioline, Banner Health, Laguna Diagnostics, AOP Health, BD, BIOTRONIK, Crown Bioscience, and more.
In this monthly report you will find news and highlights in the Applied Life Sciences from CMS, OFD Life Sciences, Perceptive eClinical, iPerf, Relaxera, BIOTRONIK, Verana Health, Matricelf, Touchlight, neuroClues, BSM Biotech, Neurizon Therapeutics Limited, Biotium, Quintessence Biotech, Kupando, and more.
In this monthly report you will find news and highlights in the Applied Life Sciences from Kandu, Devonian Health Group, Broth, LEON, Vygon, Ibex Medical Analytics, Certara, Model N, Coriolis Pharma, Bioxytran, Neurizon Therapeutics Limited, BIOTRONIK, Devonian Health Group, LEON, Harro Höfliger, ProBioGen, CubaseBio, BioMed X and more.
In this monthly report you will find news and highlights in the Applied Life Sciences from BioMed X, ConcertAI, UCSF, Michigan Integrative Health Stem Cells, Kandu, Biotium, PhaseV, Freudenberg Medical, Vetter, MetP Pharma AG, Hemex Health, ONWARD Medical and more.
Nurses can NOW apply for evidence based practice and research grants available through the DAISY Foundation. Letters of Intent due September 5, 2018.